Merit Medical Systems, Inc. (MMSI)

Merit Medical Systems Stock Forecast

Stock Price Forecast

According to 8 professional analysts, the 12-month price target for Merit Medical Systems stock ranges from a low of $93 to a high of $120. The average analyst price target of $105.38 forecasts a 26.31% increase in the stock price over the next year.

Price Target: $105.38 (+26.31%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$93	$105.38	$108	$120
Change	+11.47%	+26.31%	+29.45%	+43.83%

Analyst Ratings

The average analyst rating for Merit Medical Systems stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	2	2	2	2	2	2
Buy	6	6	6	6	6	6
Hold	1	1	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $106	Buy	Maintains	$106	+27.05%	Nov 14, 2025
Jon Young Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $104 → $93	Strong Buy	Maintains	$104 → $93	+11.47%	Nov 14, 2025
Larry Biegelsen Wells Fargo	Wells Fargo	Buy Maintains $103 → $95	Buy	Maintains	$103 → $95	+13.87%	Nov 14, 2025
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $103 → $106	Buy	Maintains	$103 → $106	+27.05%	Oct 31, 2025
Jason Bednar Piper Sandler	Piper Sandler	Buy Reiterates $105 → $109	Buy	Reiterates	$105 → $109	+30.65%	Oct 31, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.54B

Increased by 13.53%

from 1.36B

Revenue Next Year

1.64B

Increased by 6.30%

from 1.54B

EPS This Year

3.81

Increased by 87.60%

from 2.03

EPS Next Year

4.09

Increased by 7.45%

from 3.81

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	963.88M	1.07B	1.15B	1.26B	1.36B	1.54B	1.64B
Revenue Growth	-3.11%	11.50%	7.09%	9.24%	7.89%	13.53%	6.30%
EPS	-0.18	0.84	1.29	1.62	2.03	3.81	4.09
EPS Growth	-	-	53.57%	25.58%	25.31%	87.60%	7.45%
Forward PE	-	-	-	-	-	21.91	20.39
No. Analysts	-	-	-	-	-	13	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	1.6B	1.7B
Avg	1.5B	1.6B
Low	1.5B	1.5B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	17.1%	10.9%
Avg	13.5%	6.3%
Low	9.0%	0.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	3.94	4.41
Avg	3.81	4.09
Low	3.64	3.79

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	94.0%	15.8%
Avg	87.6%	7.4%
Low	79.1%	-0.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.